To ask the Secretary of State for Health, what assessment he has made of the availability of pneumococcal vaccine to (a) children, (b) adults under the age of 65 in at-risk groups and (c) adults over the age of 65; and if he will make a statement.
17 June 2014
The objective of the immunisation programme against pneumococcal infection is to protect individuals for whom such infection is likely to be more common and/or serious. The following groups are eligible for vaccination under the national immunisation programme:
- infants as part of the routine childhood immunisation programme;
- those aged 65 years or over; and
- children and adults in the clinical risk groups.
We are not aware of any supply problems with pneumococcal vaccines.
The levels of uptake of pneumococcal vaccines are high. Latest uptake figures show that 94.4% of children in England had completed a primary immunisation course of pneumococcal conjugate vaccine at 12 months of age in 2012-13. This compares with 94.2% in 2011-12. Corresponding figures in adults aged 65 years or over for pneumococcal polysaccharide vaccine was 69.1% in 2012-13 compared to 68.3% in 2011-12.